Nitric oxide synthases inhibition results in renal failure improvement in cirrhotic rats

Liver International

Volumn 25, Issue 1, 2005, Pages 131-140

  Islas Carbajal, M C ^a   Covarrubias, A ^a,b   Grijalva, G ^a   Alvarez Rodriguez A ^a   Armendariz Borunda J ^a,b   Rincón Sánchez, Ana Rosa ^a  

^a UNIVERSITY OF GUADALAJARA   (Mexico)

^b OPD Hospital Juan I Menchaca   (Mexico)

Author keywords

Cirrhosis; Decompensated cirrhosis; Nitric oxide; Nitric oxide expression; Nitric oxide synthases inhibition; Renal failure end stage cirrhosis

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINOGUANIDINE; ASPARTATE AMINOTRANSFERASE; CARBON TETRACHLORIDE; COMPLEMENTARY DNA; CREATININE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; RNA; SODIUM;

ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHI SQUARE TEST; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENE OVEREXPRESSION; HISTOPATHOLOGY; KIDNEY FAILURE; KIDNEY FUNCTION; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER INJURY; MALE; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SODIUM BLOOD LEVEL; STUDENT T TEST;

ANIMALS; ASPARTATE AMINOTRANSFERASES; CREATININE; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; GUANIDINES; KIDNEY; KIDNEY FAILURE; LIVER; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; RATS; RATS, WISTAR; RNA, MESSENGER; SODIUM;

EID: 14544289526     PISSN: 14783223     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2005.01018.x     Document Type: Article

References (17)

1. Martin P Y, Ginés P, Schrier R W. Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis. N Engl J Med 1998; 339(8): 533-41.
2. Moncada S, Palmer R, Higgs E. Nitric oxide: physiology, pathophysiology, and pharmacology (Review). Pharmacol Rev 1991; 43: 109-42.
3. Mattson D L, Wu F. Nitric oxide synthase activity and isoforms in rat renal vasculature. Hypertension 2000; 35(Part 2): 337-41.
4. Mohaupt M G, Elzie J L, Ahn K Y, Clapp W L, Wilcox C S, Kone B C. Differential expression and induction of mRNAs encoding two inducible nitric oxide synthases in rat kidney. Kidney Int 1994; 46: 653-65.
5. 4 on renal function in cirrhortic and non-cirrhotic rats. Exp Toxic Pathol 1999; 51: 199-205.
6. 2 alleviates kidney and liver damage, decreases plasma rennin activity and acute phase response in cirrhotic rats with acute liver damage. Exp Toxic Pathol 2004 (in press).
7. Ortíz M C, Fortepiani L A, Martínez C, Atucha N M, García-Estan J. Renal and pressor effects of aminoguanidine in cirrhotic rats with ascites. J Am Soc Nephrol 1996; 7: 2694-9.
8. Martin P Y, Ohara M, Gines P, Xu D L, St John J, Niederberger M, Schrier R W. Nitric oxide synthase (NOS) inhibition for one week improves renal sodium and water excretion in cirrhotic rats with ascites. J Clin Invest 1998; 101: 235-42.
9. Schwartz D, Mendonca M, Schwartz I, Xia Y, Satriano J, Wilson C B, Blantz R C. Inhibition of constitutive nitric oxide synthase (NOS) by nitric oxide generated by inducible NOS after lipopolysaccharide administration provokes renal dysfunction in rats. J Clin Invest 1997; 100: 439-48.
10. García L, Hernández I, Sandoval A, Salazar A, García J, Vera J, Grijalva G, Muriel P, Margolin S, Armendáriz-Borunda J. Pirfenidone effectively reverses experimental liver fibrosis. J Hepatol 2002; 37: 797-805.
11. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate phenol chloroform extraqction. Anal Biochem 1987; 162: 156-9.
12. Bueno M R, Daneri A, Armendariz-Borunda J. Cholestasis induced fibrosis is reduced by interferon -2a and is associated with elevated liver metalloprotease activity. J Hepatol 2000; 33: 915-25.
13. Zhou X J, Laszik Z, Ni Z, Wang X Q, Brackett D J, Lerner M R, Silva F G, Vaziri N D. Down-regulation of renal endothelial nitric oxide synthase expression in experimental glomerular thrombotic microangiopathy. Lab Invest 2000; 80(7): 1079-87.
14. Schwöbel J, Fischer T, Lanz B, Mohaupt M. Angiotensin II receptor subtypes determine induced NO production in rat glomerular mesangial cells. Am J Physiol Renal Physiol 2000; 279: F1092-100.
15. Ortiz M C, Fortepiani L A, Martínez-Salgado C, Eleno N, Atucha N M, López-Novoa J M, García-Estañ J. Efectos renales de la inhibición crónica de la síntesis de óxido nítrico en ratas cirróticas con ascitis. Nefrología 2001; XXI: 6.
16. Niederberger M, Martin P Y, Gines P, Morris K, Tsai P, Xu D L, McMurtry I, Schrier R W. Normalization of nitric oxide production corrects arterial vasodilation and hyperdynamic circulation in cirrhotic rats. Gastroenterology 1995; 109(5): 1624-30.
17. Ichihara A, Hayashi M, Navar L G, Saruta T. Inducible nitric oxide synthase attenuates endothelium-dependent renal microvascular vasodilation. J Am Soc Nephrol 2000; 11: 1807-12.